GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
RAFAX
Price
$36.10
Change
-$0.77 (-2.09%)
Updated
Feb 21 closing price
Net Assets
89.95B
Ad is loading...

GFACX vs RAFAX

Header iconGFACX vs RAFAX Comparison
Open Charts GFACX vs RAFAXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
American Funds AMCAP R1
Price$36.10
Change-$0.77 (-2.09%)
VolumeN/A
Net Assets89.95B
GFACX vs RAFAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RAFAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RAFAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. RAFAX (90B). GFACX (0.00) and RAFAX (0.00) have matching dividends . GFACX was incepted earlier than RAFAX: GFACX (24 years) vs RAFAX (23 years). GFACX (31.00) and RAFAX (31.00) have comparable annual turnover. GFACX (250) and RAFAX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 10.15 vs. RAFAX (4.52). GFACX return over 5 years is better than : 32.83 vs. RAFAX (16.26).
GFACXRAFAXGFACX / RAFAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD2.9801.977151%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets304B90B338%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.154.52225%
Returns for 3 years17.698.25215%
Returns for 5 years32.8316.26202%
Returns for 10 years55.6332.67170%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding